Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MAYNF MAYNE PHARMA GROUP LIMITED

Watchlist
0.145
-0.025-14.71%
Close 12/02 16:00 ET
High
0.177
Open
0.141
Turnover
1.08K
Low
0.141
Pre Close
0.170
Volume
7.12K
Market Cap
252.27M
P/E(TTM)
Loss
52wk High
0.293
Shares
1.74B
P/E(Static)
Loss
52wk Low
0.141
Float Cap
252.27M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
0.65
Historical Low
0.141
Dividend TTM
--
Div Yield TTM
--
P/B
0.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
21.00%
Avg Price
0.151
Lot Size
1
Float Cap
252.27M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
0.65
Historical Low
0.141
Dividend TTM
--
P/B
0.66
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
21.00%
Avg Price
0.151
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

    No comment yet

    Company Overview More
    Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
    CEO: Mr. Shawn Patrick O’Brien
    Market: Pink Market
    Hot List
    TradeSearchNews
    SymbolLatest price%Chg

    Loading...

    Watchlist